KNSA logo

Kiniksa Pharmaceuticals (KNSA) return on equity

annual ROE:

-9.85%-13.22%(-392.28%)
December 31, 2024

Summary

  • As of today (May 30, 2025), KNSA annual return on equity is -9.85%, with the most recent change of -13.22% (-392.28%) on December 31, 2024.
  • During the last 3 years, KNSA annual ROE has risen by +53.70% (+84.50%).
  • KNSA annual ROE is now -110.57% below its all-time high of 93.16%, reached on December 31, 2016.

Performance

KNSA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAprofitability metrics

quarterly ROE:

-3.85%+6.05%(+61.11%)
March 31, 2025

Summary

  • As of today (May 30, 2025), KNSA quarterly return on equity is -3.85%, with the most recent change of +6.05% (+61.11%) on March 31, 2025.
  • Over the past year, KNSA quarterly ROE has dropped by -5.93% (-285.10%).
  • KNSA quarterly ROE is now -105.32% below its all-time high of 72.32%, reached on December 31, 2017.

Performance

KNSA quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

KNSA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-392.3%-285.1%
3 y3 years+84.5%+93.8%
5 y5 years+86.3%+92.5%

KNSA ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-115.6%+84.5%-105.4%+93.8%
5 y5-year-115.6%+86.3%-105.4%+94.5%
alltimeall time-110.6%+86.3%-105.3%+97.1%

KNSA ROE History

DateAnnualQuarterly
Mar 2025
-
-3.85%(-61.1%)
Dec 2024
-9.85%(-392.3%)
-9.90%(+369.2%)
Sep 2024
-
-2.11%(-12.4%)
Jun 2024
-
-2.41%(-215.9%)
Mar 2024
-
2.08%(-39.7%)
Dec 2023
3.37%(-94.7%)
3.45%(-305.4%)
Sep 2023
-
-1.68%(-102.5%)
Jun 2023
-
66.63%(+1.2%)
Mar 2023
-
65.87%(-7.7%)
Dec 2022
63.10%(-199.3%)
71.35%(+10.4%)
Sep 2022
-
64.64%(-210.1%)
Jun 2022
-
-58.70%(-5.9%)
Mar 2022
-
-62.35%(-10.6%)
Dec 2021
-63.55%
-69.76%(+2.7%)
Sep 2021
-
-67.90%(+6.0%)
DateAnnualQuarterly
Jun 2021
-
-64.08%(+3.5%)
Mar 2021
-
-61.92%(+8.1%)
Dec 2020
-51.74%(-27.9%)
-57.29%(+6.8%)
Sep 2020
-
-53.65%(+2.0%)
Jun 2020
-
-52.59%(+2.9%)
Mar 2020
-
-51.11%(-16.4%)
Dec 2019
-71.81%(+94.3%)
-61.14%(-1.5%)
Sep 2019
-
-62.05%(+7.7%)
Jun 2019
-
-57.63%(+17.3%)
Mar 2019
-
-49.12%(+36.3%)
Dec 2018
-36.96%(-151.1%)
-36.05%(-25.0%)
Sep 2018
-
-48.09%(-13.7%)
Jun 2018
-
-55.71%(-57.5%)
Mar 2018
-
-131.15%(-281.3%)
Dec 2017
72.32%(-22.4%)
72.32%
Dec 2016
93.16%
-

FAQ

  • What is Kiniksa Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual ROE year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly ROE year-on-year change?

What is Kiniksa Pharmaceuticals annual return on equity?

The current annual ROE of KNSA is -9.85%

What is the all time high annual ROE for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual return on equity is 93.16%

What is Kiniksa Pharmaceuticals annual ROE year-on-year change?

Over the past year, KNSA annual return on equity has changed by -13.22% (-392.28%)

What is Kiniksa Pharmaceuticals quarterly return on equity?

The current quarterly ROE of KNSA is -3.85%

What is the all time high quarterly ROE for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly return on equity is 72.32%

What is Kiniksa Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, KNSA quarterly return on equity has changed by -5.93% (-285.10%)
On this page